美年健康(002044) - 2025 Q2 - 季度业绩预告

Meinian Onehealth 2025 Semi-Annual Performance Forecast Performance Forecast Overview The company forecasts H1 2025 revenue between 3.96 billion and 4.20 billion yuan, with a net loss of 192 million to 236 million yuan, while AI business revenue grew 62.36% Performance Forecast Summary | Item | Current Period (2025H1) | Prior Period (2024H1) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 3.96 – 4.20 Billion Yuan | 4.205 Billion Yuan | Decrease 0.12% – 5.83% | | Net Profit Attributable to Shareholders | Loss: 192 – 236 Million Yuan | Loss: 215.7772 Million Yuan | Decrease 9.37% – Increase 11.02% | | Net Profit Excluding Non-Recurring Items | Loss: 205 – 253 Million Yuan | Loss: 224.5164 Million Yuan | Decrease 12.69% – Increase 8.69% | | Basic Earnings Per Share | Loss: 0.05 – 0.06 Yuan/Share | Loss: 0.06 Yuan/Share | - | - Main business revenue incorporating AI technologies (e.g., cardio-pulmonary joint screening, AI-MDT reports) reached 140.4159 million yuan, a significant 62.36% increase from the prior year[3] Explanation of Performance Changes Performance changes are mainly due to the H1 off-peak season and macroeconomic factors, causing some corporate clients to delay examinations, while the company maintained stable individual market metrics and prepared for the peak season - Macroeconomic conditions led some corporate clients to postpone budgets and medical examinations during the traditional H1 off-peak season, impacting revenue[5] - Overall order signing, average customer spending, and the individual examination market remained relatively stable, with ongoing efforts to convert group examination clients to individual ones[5] - The company made progress in cost reduction and efficiency improvement through AI and digital means in H1, laying the groundwork for the H2 peak examination season[6] Other Relevant Information This performance forecast is a preliminary, unaudited estimate from the financial department, advising investors of risks, with final data to be disclosed in the official semi-annual report - The financial data in this performance forecast is unaudited by certified public accountants[4] - This forecast represents preliminary estimates by the company's financial department; final accurate financial data will be disclosed in the 2025 semi-annual report[7]